These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Andrews PW; Bharwani A; Lee KR; Fox M; Thomson JA Neurosci Biobehav Rev; 2015 Apr; 51():164-88. PubMed ID: 25625874 [TBL] [Abstract][Full Text] [Related]
26. Serotonergic mechanisms and the new antidepressants. Stahl SM Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642 [No Abstract] [Full Text] [Related]
27. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus. Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120 [TBL] [Abstract][Full Text] [Related]
28. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. DeBattista C; Sofuoglu M; Schatzberg AF Biol Psychiatry; 1998 Sep; 44(5):341-7. PubMed ID: 9755356 [TBL] [Abstract][Full Text] [Related]
29. The neuropharmacology of serotonin and noradrenaline in depression. Nutt DJ Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606 [TBL] [Abstract][Full Text] [Related]
30. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Cremers TI; Rea K; Bosker FJ; Wikström HV; Hogg S; Mørk A; Westerink BH Neuropsychopharmacology; 2007 Jul; 32(7):1550-7. PubMed ID: 17203017 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of trazodone: a multifunctional drug. Stahl SM CNS Spectr; 2009 Oct; 14(10):536-46. PubMed ID: 20095366 [No Abstract] [Full Text] [Related]
35. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. Blier P; Szabo ST J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034 [TBL] [Abstract][Full Text] [Related]
36. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Kaster MP; Santos AR; Rodrigues AL Brain Res Bull; 2005 Sep; 67(1-2):53-61. PubMed ID: 16140163 [TBL] [Abstract][Full Text] [Related]
37. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. Freemantle N; Anderson IM; Young P Br J Psychiatry; 2000 Oct; 177():292-302. PubMed ID: 11116769 [TBL] [Abstract][Full Text] [Related]
38. Prescribing update: why choose duloxetine for depression? Tobin ML Issues Ment Health Nurs; 2007 Jan; 28(1):117-20. PubMed ID: 17130011 [No Abstract] [Full Text] [Related]
39. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents. Dubovsky SL J Clin Psychiatry; 1994 Feb; 55 Suppl():34-44. PubMed ID: 8077173 [TBL] [Abstract][Full Text] [Related]